HOLD; stop at 60.40; scale in at support zones (50 SMA, Bollinger lower band, 200 SMA); dry powder at 60-58 with invalidation below 58

• Management's buyback pause signals internal skepticism about current valuation, not capital discipline
• Gross margins remain depressed and plateaued: Q4 2025 at 26.8%, Q1 2026 at 28.2%, Q2 2026 at 27.8% — no mid-stream recovery despite easing cocoa costs
• Revenue growth of 8.2% year-over-year is pricing-driven, not margin-driven; conflating top-line acceleration with margin expansion risks a value trap
• 93% Fed hold probability is not unambiguously bullish — hawkish hold with rising real yields is a headwind for duration-sensitive defensives like MDLZ
• MACD histogram below zero for 11 straight sessions; 20 SMA at 62.77 has capped every rebound attempt over 10 sessions — contracting range near resistance fails more often than it breaks out
• True reward-to-risk is 1.19-to-1 (2.02-point stop vs 64.82 target), not 2-to-1; genuine 2-to-1 would require ~66.40 target near 52-week high
• 3.33% dividend yield equals 0.83% per quarter; 2.02-point stop risk equals 100% of four quarters of dividend income on same exposure — principal risk exceeds years of income
• Base rate risks are correlated: cocoa spikes (3 of last 5 years), EM FX shocks, and health trends all share common macro factor of stronger dollar
• Adding at 62.42 increases exposure closer to resistance than support with momentum against the trade
• Proper response is preserving capital through uncertainty; existing position plus dividend reinvestment captures upside if breakout occurs without adding at suboptimal entry

→ vs aggressive: Management's buyback pause is not capital discipline but a bearish signal — insiders are not adding exposure at 62-63, contradicting the bullish add-now thesis

→ vs aggressive: Revenue growth (8.2% YoY) is pricing-driven while gross margins remain plateaued at depressed 27.8% — conflating top-line acceleration with margin expansion is the central vulnerability of the bull case

→ vs aggressive: 93% Fed hold probability is an oversimplification; hawkish hold with rising real yields is a headwind for duration of cash flows, and flight-to-quality bid historically arrives after broader market correction

→ vs aggressive: ATR compression near overhead resistance fails more often than it breaks out; 62.77 level cannot be selectively dismissed when it sits 1.5 points below current price and has capped every rebound

→ vs aggressive: Adjusted reward-to-risk is 1.19-to-1, not 2-to-1; once factoring slippage, time value, and ~50% breakout failure probability at these levels, expected value is significantly worse than headline ratio

→ vs aggressive: 3.33% dividend does not pay for the risk — 2.02-point stop equals 100% of four quarters of dividend income, making it a speculative bet masked by income narrative

→ vs aggressive: Bear case risks (cocoa spikes, EM FX shocks, health trends) are correlated through stronger dollar regime, not independent tail risks as the bull case assumes

HOLD with partial scale-in: maintain existing position; add smaller initial tranche (half-size) between $61.80 and $62.20; keep stop at $60.40; second tranche contingent on breakout above $64.82 or pullback to $60.40 with RSI above 40; continue dividend reinvestment

• Q4 2025 gross margin at 26.8%, Q1 at 28.2%, Q2 at 27.8% - oscillation around depressed mean, not clean recovery trajectory
• Forward EPS of $3.36 is already priced in; if margins don't expand on consensus timeline, multiple compression follows
• ATR compression signals market indecision awaiting catalyst, not directional move - aggressive analyst misreads this as coiled spring
• MACD negative for 11 sessions; 20 SMA rejected every rebound for 10 sessions; histogram still lengthening negative
• 50 SMA bought on every touch this year - real structural feature supporting breakdown thesis is overcorrecting
• Reward-to-risk: $2.02 stop against $64.82 target = 1.19:1; $2.02 stop against $66.50 target = ~2:1 (upper bound)
• 3.33% dividend yield is competitive versus alternatives but not a subsidy for principal risk at full price
• $60.40 stop level breaks both 50 SMA and Bollinger lower band simultaneously, shifting technical regime meaningfully
• Fed hold creates defensive-friendly regime but doesn't automatically mean MDLZ outperforms - holds up better than cyclicals in drawdown
• Scale-in entry revised upward from $60.40 to $61.80-$62.20 zone based on 50 SMA reliability; requires 3.2% drawdown for conservative plan to trigger
• Probability-weighted picture is genuinely 50-50 at these levels; expected value depends on whether structural uptrend or near-term rejection pattern matters more
• Macro hedge concern: defensive rotation can reverse sharply on hawkish Fed surprise or rising recession probabilities

→ vs aggressive: On buyback pause: calling management cowardly for doing the same thing (waiting for better prices) is selective logic - inconsistency with own framework

→ vs aggressive: On ATR compression: calling it a coiled spring is a misread - contracting volatility signals undecided market awaiting catalyst, not directional resolution

→ vs aggressive: On reward-to-risk math: $2.02 stop against $64.82 target is ~1.19:1, not 2:1 as claimed; sloppy framing that overstates the case

→ vs aggressive: On dividend: 'every quarter you wait is a quarter of dividend income you didn't capture' is materially misleading - confuses new-position yield with cost-of-waiting on existing exposure

→ vs aggressive: On entry timing: adding at $62.42 with negative momentum and at resistance is paying full price for unvalidated thesis; wrong timing

→ vs conservative: On margins: overcorrects by treating plateau as near-collapse; Q2 27.8% came against elevated cocoa costs; pricing power demonstrated; recovery more likely than not, just slower

→ vs conservative: On technical breakdown thesis: treating every failed 20 SMA push as definitive bearish pattern is selection bias; ignores structural 50 SMA support

→ vs conservative: On waiting for $60.40: plan may never trigger; stock has bounced off 50 SMA at $61.59 every time; demanding 3.2% drawdown is overcorrecting

→ vs conservative: On probability-weighted downside: claiming real downside is twice upside is hand-wavy; assumes 200 SMA test is modal outcome without justification